ICW Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.07M Sell
3,339
-2,313
-41% -$2.34M 1.11% 30
2025
Q4
$6.07M Buy
5,652
+41
+0.7% +$39.2K 2.21% 4
2025
Q3
$4.28M Sell
5,611
-318
-5% -$237K 1.54% 13
2025
Q2
$4.62M Sell
5,929
-701
-11% -$545K 1.83% 9
2025
Q1
$5.48M Buy
6,630
+15
+0.2% +$12.5K 2.23% 5
2024
Q4
$5.11M Buy
6,615
+6,089
+1,158% +$5.04M 2.13% 6
2024
Q3
$467K Buy
526
+43
+9% +$38.7K 0.19% 119
2024
Q2
$437K Sell
483
-8
-2% -$6.4K 0.2% 119
2024
Q1
$382K Buy
491
+68
+16% +$48.4K 0.17% 125
2023
Q4
$247K Buy
423
+38
+10% +$22.2K 0.12% 135
2023
Q3
$207K Buy
+385
New +$198K 0.11% 135

Other funds holding LLY

ICW Investment Advisors's LLY Position: Q1 2026 in Review

ICW Investment Advisors reduced its Eli Lilly (LLY) stake by 41% in Q1 2026, selling an estimated $2.34M and leaving 3,339 shares worth $3.07M. The position accounts for 1.11% of the portfolio, ranked #30.

ICW Investment Advisors first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.07M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ICW Investment Advisors held 3,339 shares of Eli Lilly worth $3.07M as of Q1 2026.
  • ICW Investment Advisors sold 2,313 Eli Lilly shares in Q1 2026, an estimated $2.34M.
  • Eli Lilly made up 1.11% of ICW Investment Advisors's portfolio in Q1 2026, its #30 holding.
  • ICW Investment Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • ICW Investment Advisors's Eli Lilly position peaked at $6.07M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ICW Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.